ABSTRACT NUMBER: ESOC2026A1188 DUAL ANTIPLATELET THERAPY DURATION FOLLOWING STENT-ASSISTED MECHANICAL THROMBECTOMY-A REGIONAL CENTRE EXPERIENCE
Raisul Sharior, Sudhir Vigneshwar, Lateefa Jomoh, Jessica Redgrave, Joyce Balami · 2026
Read ABSTRACT NUMBER: ESOC2026A1188 DUAL ANTIPLATELET THERAPY DURATION FOLLOWING STENT-ASSISTED MECHANICAL THROMBECTOMY-A REGIONAL CENTRE EXPERIENCE by Raisul Sharior, Sudhir Vigneshwar, Lateefa Jomoh, Jessica Redgrave, Joyce Balami (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13146954.txt.
Description
Raisul Sharior and co-authors report a 2026 conference audit of how long paired clot drugs run after a stent is placed during stroke care. Care rules back the drugs after stenting, but they give no firm length for this setting. Gaps in discharge notes can cause harm when patients move between hospitals.
The audit reviewed sixty-seven stented cases from 2018 to 2025 at one regional center. About three of four discharge notes stated the drugs with a clear stop or review date. Planned lengths varied a lot, with twelve weeks the most common choice. Just over half of cases fell inside the four-to-twelve-week guide band. The authors call for standard plans and required note fields.
Catalog record
| CREATOR | Raisul Sharior, Sudhir Vigneshwar, Lateefa Jomoh, Jessica Redgrave, Joyce Balami |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |